U.S. Stock News

NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Is Casella Waste Systems (CWST) Pricing Reflect Its Role In Regional Waste And Recycling Services

If you are wondering whether Casella Waste Systems at around US$103.88 is priced attractively or asking too much, you are in the right place for a closer look at what that means for you as a shareholder or potential investor. The stock has returned 5.3% year to date, with a 0.3% decline over the last 7 days, a 2.1% decline over 30 days, a 9.7% decline over 1 year, 35.5% total return over 3 years and 75.4% total return over 5 years. Recent news around Casella Waste Systems has largely focused...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

A Look At BridgeBio Pharma (BBIO) Valuation After Positive Phase 3 PROPEL 3 Achondroplasia Results

BridgeBio Pharma (BBIO) has become a focus for investors after reporting positive topline results from its global Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia. See our latest analysis for BridgeBio Pharma. The positive PROPEL 3 data sits alongside a very strong 1-year total shareholder return of 113.72% and a roughly 7x total shareholder return over 3 years. The 90-day share price return of 15.73% suggests momentum has recently picked up again, despite a softer...
NYSE:IOT
NYSE:IOTSoftware

Is Samsara (IOT) Offering An Opportunity After A 57% One Year Share Price Decline

If you are trying to figure out whether Samsara's current share price reflects its real worth, you are not alone. Many investors are asking the same question. The stock recently closed at US$26.16, with a 6.2% decline over the last 7 days, a 25.0% decline over 30 days, a 22.9% decline year to date, and a 57.1% decline over 1 year. However, the 3 year return sits at 61.4%. Recent attention on Samsara has been shaped by ongoing interest in connected operations software and how companies in...
NYSE:MC
NYSE:MCCapital Markets

Moelis (MC) Expands Buybacks And Dividends – What Does This Reveal About Its Margin Story?

In early February 2026, Moelis & Company reported fourth-quarter 2025 net income of US$87.87 million and full-year net income of US$233.04 million, alongside a regular quarterly dividend of US$0.65 per share payable on March 26, 2026 to holders of record on February 17, 2026. On the same day, the firm completed a multi-year US$196.47 million buyback and launched a new, open-ended US$300 million repurchase program, reinforcing a capital return approach that pairs earnings growth with...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

A Look At Mondelez International’s (MDLZ) Valuation As CAGNY Growth Plans And Saudi Expansion Draw Interest

Recent attention on Mondelez International (MDLZ) has centered on its 2026 CAGNY Conference messaging regarding long term growth plans and the appointment of Ziad Abla to lead Mondelez Arabia in Saudi Arabia. See our latest analysis for Mondelez International. Against this backdrop of conference messaging, dividends and buybacks, Mondelez International’s share price has a 30 day return of 4.6% and a year to date share price return of 11.6%, while the 5 year total shareholder return sits at...
NYSE:JCI
NYSE:JCIBuilding

Assessing Johnson Controls International (NYSE:JCI) Valuation After Strong Q1 Revenue And Net Income Growth

Johnson Controls International (NYSE:JCI) has attracted fresh attention after reporting first quarter revenue of US$5,797 million and net income of US$524 million, along with higher earnings per share from continuing operations compared with a year earlier. See our latest analysis for Johnson Controls International. The recent earnings release and the omnibus shelf registration appear to have coincided with stronger interest in Johnson Controls International, with the 30 day share price...
NYSE:BTGO
NYSE:BTGOCapital Markets

Is There Now An Opportunity In Bitgo Holdings (BTGO) After 41% Year To Date Share Price Fall

If you are trying to figure out whether Bitgo Holdings at around US$10.87 is a bargain or a value trap, starting with a clear view of what the current price reflects can help you frame the opportunity and the risks. The stock has seen a 1.4% decline over the last 7 days and a 41.2% decline year to date, which can change how the market views its growth potential and risk profile. Recent coverage around Bitgo Holdings has focused on its role in digital asset custody and broader crypto market...
NYSE:DVN
NYSE:DVNOil and Gas

Is Devon Energy (DVN) Still Attractively Priced After Its Recent Share Price Rally?

Investors may be wondering whether Devon Energy at around US$44.04 is offering good value right now, or if most of the opportunity is already priced in. The stock has returned 1.3% over the last 7 days, 21.7% over the last 30 days, 16.3% year to date, 29.8% over 1 year, and 164.3% over 5 years, while the 3 year return sits at a 7.4% decline. This gives a mixed picture of how the market has treated the shares over time. Recent coverage has focused on Devon Energy's position in the US energy...
NYSE:FR
NYSE:FRIndustrial REITs

The Bull Case For First Industrial Realty Trust (FR) Could Change Following Double-Digit Dividend Hike Amid EPS Decline

In early February 2026, First Industrial Realty Trust reported higher fourth-quarter 2025 revenue of US$188.41 million and net income of US$78.85 million, issued 2026 net income guidance of US$1.58–US$1.68 per share, and approved a quarterly dividend increase to US$0.50 per share. While full-year 2025 sales rose to US$727.08 million, net income and earnings per share declined versus 2024, making the double-digit dividend hike a particularly important signal about management’s confidence in...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Should Black Hills’ 2025 Earnings Growth and Higher Sales Require Action From Black Hills (BKH) Investors?

In February 2026, Black Hills Corporation reported past fourth-quarter 2025 results showing sales of US$635.5 million and net income of US$104.9 million, with diluted earnings per share from continuing operations of US$1.39. For the full year 2025, Black Hills grew sales to US$2.31 billion and net income to US$291.6 million, with diluted continuing EPS of US$3.98, highlighting consistent year-on-year earnings expansion. We’ll now consider how this earnings growth, particularly the full-year...
NYSE:WEX
NYSE:WEXDiversified Financial

WEX (WEX) Faces Activist Proxy Fight: Is Capital Allocation Undermining Its Competitive Narrative?

In February 2026, activist investor Impactive Capital escalated pressure on WEX Inc. by launching a proxy contest, nominating four directors and criticizing the company’s operating margins, governance, and long-term performance versus peer Corpay. This challenge comes after WEX completed a US$1.88 billion share repurchase program and reported higher quarterly earnings per share despite largely flat full-year net income, sharpening the focus on how capital has been deployed. We’ll now examine...
NasdaqGM:CAN
NasdaqGM:CANTech

A Look At Canaan (NasdaqGM:CAN) Valuation After Earnings, 2026 Guidance And January Bitcoin Production Update

Why Canaan’s latest numbers matter for shareholders Canaan (NasdaqGM:CAN) just released fourth quarter and full year 2025 results, fresh earnings guidance for the first quarter of 2026, and January Bitcoin production data, giving investors several new reference points to assess the stock. For the fourth quarter ended December 31, 2025, Canaan reported revenue of US$196.27 million, compared with US$88.77 million a year earlier. The company recorded a net loss of US$85.04 million for the...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

A Look At RLJ Lodging Trust (RLJ) Valuation After Comprehensive Debt Refinancing Reset

RLJ Lodging Trust (RLJ) has fully refinanced its debt maturities through 2028 by extending its revolver, reshaping term loans, and refinancing 2026 secured debt to push the next maturity out to 2029. See our latest analysis for RLJ Lodging Trust. At a share price of $8.29, RLJ Lodging Trust has seen an 8.2% 1 month share price return and a 13.7% 3 month share price return, yet its 1 year total shareholder return of 7.9% decline shows that recent momentum is still working to offset a weaker...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

A Look At Fox (FOXA) Valuation After Recent Share Price Weakness

Why Fox stock is on investors’ radar today Fox (FOXA) has drawn attention after a recent move in its share price, with the stock showing a 0.1% gain over the past day but a 10.9% decline over the past week. See our latest analysis for Fox. At a share price of $56.43, Fox’s recent 7 day and 30 day share price returns of 10.95% and 21.61% declines highlight fading short term momentum, despite 3 year and 5 year total shareholder returns of 62.38% and 76.50%. If Fox’s recent pullback has you...
NYSE:GMED
NYSE:GMEDMedical Equipment

A Look At Globus Medical (GMED) Valuation After Recent Analyst Upgrades And Preliminary Q4 Revenue Update

Recent analyst calls around Globus Medical (GMED) have sharpened the market’s focus on the stock, following positive preliminary fourth quarter revenue, commentary on margin expansion, and fresh coverage tied to Nevro, international growth, and enabling technologies. See our latest analysis for Globus Medical. The recent upgrade and new coverage come after a period where short term share price momentum has cooled, with a 30 day share price return showing a 4.78% decline. In contrast, the 3...
NYSE:CRL
NYSE:CRLLife Sciences

New Charles River Leaders May Shape Valuation, Debt And Governance Outlook

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench. These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance. Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...
NYSE:BCO
NYSE:BCOCommercial Services

Did Brink’s Operations Veteran Appointment to Lead North America Just Shift Brink's (BCO) Investment Narrative?

The Brink’s Company has appointed Adrian Button as executive vice president and president of Brink’s North America, effective February 16, 2026, adding him to the executive leadership team reporting to CEO Mark Eubanks. With more than 30 years of global operational leadership at GE, NCR, and Carrier overseeing multibillion-dollar businesses and large-scale supply chains, Button’s background directly aligns with Brink’s focus on operational efficiency and service quality in North...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Is Texas Capital Bancshares (TCBI) Still Attractive After Strong Multi‑Year Share Price Gains

If you are wondering whether Texas Capital Bancshares at around US$104 is offering good value or asking too much, you are in the right place. The stock closed at US$104.37 recently, with returns of 1.3% over the last week, 6.5% over the last month, 13.8% year to date, 27.0% over one year and 60.3% over three years, as well as 30.9% over five years. These moves may have shifted how the market views its potential and risks. Recent coverage around Texas Capital Bancshares has focused on its...
NYSE:AZO
NYSE:AZOSpecialty Retail

Is It Too Late To Consider AutoZone (AZO) After Its Strong Multi Year Rally

If you are wondering whether AutoZone's share price still reflects good value after a long run in the market, you are not alone. This article will walk through what the current valuation might be telling you. AutoZone's shares last closed at US$3,742.00, with returns of 2.1% over 7 days, 6.2% over 30 days, 13.3% year to date, 10.6% over 1 year, 45.4% over 3 years and 215.7% over 5 years. Recent coverage has focused on AutoZone's position in the US auto parts retail space, including...
NasdaqGS:BMRC
NasdaqGS:BMRCBanks

3 Stocks That May Be Trading Below Estimated Fair Value

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing 515 points and the S&P 500 nearing a record high. Amid this positive momentum, investors may find opportunities in stocks that appear to be trading below their estimated fair value, potentially offering attractive entry points in a market characterized by robust gains and evolving economic conditions.
OTCPK:CVSI
OTCPK:CVSIPersonal Products

Promising Penny Stocks To Consider In February 2026

As February 2026 kicks off, major stock indexes in the United States have shown impressive gains, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In such a buoyant market atmosphere, investors often look beyond established giants to explore opportunities in lesser-known areas like penny stocks. Although 'penny stock' is an older term, it still denotes smaller or newer companies that can offer significant potential when backed by strong...
NasdaqGS:OTTR
NasdaqGS:OTTRElectric Utilities

Otter Tail (OTTR) Margins Hold Above 21% Challenging Bearish Earnings Narrative

Otter Tail (OTTR) has just posted its FY 2025 numbers, with fourth quarter revenue of US$308.1 million and basic EPS of US$1.24, alongside trailing twelve month revenue of about US$1.3 billion and EPS of US$6.59 setting the backdrop. Over recent periods, revenue has ranged from US$303.1 million in Q4 2024 to US$337.4 million in Q1 2025, while quarterly EPS has moved between US$1.31 and US$2.04, giving investors a clear read on how margins are holding up against this revenue base. With a...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

Regencell Bioscience Holdings (RGC) Valuation After Insider Lock Up Extension And Rapid Share Price Momentum

Insider lock up extension puts Regencell Bioscience Holdings (RGC) insider activity in focus Regencell Bioscience Holdings (RGC) has extended insider lock up commitments for directors and employees by one year, covering previously granted stock options and keeping insiders restricted from selling for a longer period. See our latest analysis for Regencell Bioscience Holdings. The lock up extension comes after a sharp shift in sentiment, with a 90 day share price return of 150.16% and year to...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter International (BAX) Is Down 5.5% After Wider Losses Offset Revenue Gain And Muted 2026 Outlook

Baxter International Inc. reported past fourth-quarter 2025 sales of US$2,974 million, up from US$2,753 million a year earlier, but the company’s net loss widened to US$1,128 million amid higher goodwill impairments and ongoing margin pressures. Alongside reaffirming a modest quarterly dividend and completing a long-running share repurchase program, Baxter guided to flat to 1% U.S. GAAP sales growth for 2026, underscoring a focus on balance sheet repair and operational reshaping following...